Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Syros Pharmaceuticals (GB:0LC7)
LSE:0LC7
RESEARCH TOOLSreports
Holding GB:0LC7?
Track your performance easily
Syros Pharmaceuticals (0LC7) Ownership Overview
2.18% Insiders
4.69% Mutual Funds
0.15% Other Institutional Investors
3.62% ETFs
89.37% Public Companies and
Individual Investors
The ownership structure of Syros Pharmaceuticals (GB:0LC7) stock is a mix of institutional, retail, and individual investors. Approximately 8.45% of the company’s stock is owned by Institutional Investors, 2.18% is owned by Insiders, and 89.37% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
| Sep 12, 2024 | Jason Haas Cfo | xxxxxxxxxxxxx | $160474 |
| Sep 12, 2024 | Conley Chee President & Ceo,director | xxxxxxxxxxxxx | $160000 |
| Dec 26, 2023 | Srinivas Akkaraju Director | xxxxxxxxxxxxx | $3999998 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 1,293,849 | Institution | 4.83% | 2,526,887 | |
| 911,818 | Institution | 3.40% | 1,780,781 | |
| 909,605 | Institution | 3.39% | 1,776,459 | |
| 251,270 | Institution | 0.94% | 490,730 | |
| 210,005 | Institution | 0.78% | 410,140 | |
| 135,658 | Insider | 0.51% | 264,940 | |
| 124,552 | Insider | 0.46% | 243,250 | |
| 122,504 | Insider | 0.46% | 239,250 | |
| 116,754 | Institution | 0.44% | 228,021 | |
| 56,992 | Institution | 0.21% | 111,305 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 909,605 | Institution | 3.39% | 1,776,459 | |
| 210,005 | Institution | 0.78% | 410,140 | |
| 50,670 | Institution | 0.19% | 98,959 | |
| 23,659 | Institution | 0.09% | 46,206 | |
| 22,550 | Institution | 0.08% | 44,040 | |
| 16,667 | Institution | 0.06% | 32,551 | |
| 14,309 | Institution | 0.05% | 27,945 | |
| 4,670 | Institution | 0.02% | 9,121 | |
| 4,239 | Institution | 0.02% | 8,279 | |
| 312 | Institution | <0.01% | 609 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|
FAQ
Who Owns Syros Pharmaceuticals (GB:0LC7)?
According to the latest TipRanks data, approximately 0.15% of the company's stock is held by institutional investors, 2.18% is held by insiders, and 89.37% is held by retail investors.
What percentage of Syros Pharmaceuticals (GB:0LC7) stock is held by institutional investors?
According to the latest TipRanks data, approximately 0.15% of Syros Pharmaceuticals (GB:0LC7) stock is held by institutional investors.
What percentage of Syros Pharmaceuticals (GB:0LC7) stock is held by retail investors?
According to the latest TipRanks data, approximately 89.37% of Syros Pharmaceuticals (GB:0LC7) stock is held by retail investors.
Who owns the most shares of Syros Pharmaceuticals (GB:0LC7)?
Noubar Afeyan owns the most shares of Syros Pharmaceuticals (GB:0LC7).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.